Literature DB >> 22179920

[Erythrodermic psoriasis: epidemiological clinical and therapeutic features about 60 cases].

Abdelmoati Hawilo1, Ines Zaraa, Rym Benmously, Amel Mebazaa, Dalenda El Euch, Mourad Mokni, Amel Ben Osman.   

Abstract

BACKGROUND: the erythrodermic psoriasis (EP) is a rare but severe form of psoriasis that may be potentially life-threatening. AIM: To study the characteristics of this severe form of psoriasis.
METHODS: We present a retrospective study, including all cases of EP followed in the dermatology department of the La Rabta hospital of Tunis over a 31-year-period from January, 1980 to June, 2010.
RESULTS: sixty patients were included, concerning 46 men and 14 women, with an average age of 53.7. A history of psoriasis was reported in 78 % of the cases. A triggering factor was found in 53 % of the cases. Systemic treatments were required in 55 % of cases. An improvement was noted in 69.4 % of the cases. A recurrence of the EP was observed in 15% of the cases. Three cases of sepicemia and one of stroke were noted.
CONCLUSION: Erythrodermic psoriasis is the most common etiology of erythroderma. It represents more than half of severe psoriasis. As shown in our study it affects mainly adults' males. It complicates usually a common psoriasis. Septic and thromboembolic complications ones justify a close follow up.

Entities:  

Mesh:

Year:  2011        PMID: 22179920

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  6 in total

1.  Erythrodermic psoriasis and human immunodeficiency virus: association and therapeutic challenges.

Authors:  Fernando Valenzuela; Javier Fernández; Margarita Sánchez; Andrea Zamudio
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

2.  A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.

Authors:  Camille Luherne; Sarah Menguy; Thomas Ferte; Marie Beylot-Barry; Julien Seneschal; Brigitte Milpied; Jean-Philippe Vial; Audrey Gros; Samuel Amintas; Béatrice Vergier; Anne Pham-Ledard
Journal:  Acta Derm Venereol       Date:  2022-09-06       Impact factor: 3.875

3.  Two cases of Erythrodermic psoriasis treated with Golimumab.

Authors:  Mayssoun Kudsi; Mhd Amin Alzabibi; Mosa Shibani
Journal:  Ann Med Surg (Lond)       Date:  2022-06-08

4.  A case of erythrodermia from exacerbated psoriasis vulgaris due to treatment of acute hepatitis C.

Authors:  Eva Lemmenmeier; Barbara Gaus; Patrick Schmid; Matthias Hoffmann
Journal:  BMC Dermatol       Date:  2016-05-26

5.  Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study.

Authors:  An-Ran Ma; Fang Liu; Runnan Wang; Lanmei Lin; Yilun Wang; Qunyi Li; Xiaonian Lu; Juan Du
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-14       Impact factor: 5.555

6.  Erythrodermic psoriasis: pathophysiology and current treatment perspectives.

Authors:  Rasnik K Singh; Kristina M Lee; Derya Ucmak; Merrick Brodsky; Zaza Atanelov; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2016-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.